Cargando…

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients

Detalles Bibliográficos
Autores principales:	Canero, A, Goffredi, L, Apperti, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290195/ http://dx.doi.org/10.1186/1471-2318-10-S1-A51

Ejemplares similares

Non pharmacological venous thromboembolism prophylaxis in old surgical patients
por: Apperti, M, et al.
Publicado: (2009)

Original method in the treatment of varicose veins of the lower limbs in elderly patients candidates for orthopedic surgery
por: Goffredi, L, et al.
Publicado: (2011)

Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients
por: Sochal, M., et al.
Publicado: (2021)

Ultrasonography in pediatric inflammatory bowel diseases
por: Massimetti, Mauro, et al.
Publicado: (2014)

Ultrasound in children and adolescents with inflammatory bowel disease
por: La Seta, Francesco, et al.
Publicado: (2014)

Genes, microbiome, diet and inflammatory bowel disease
por: Baldassano, Robert N
Publicado: (2015)

P03-024 – Early onset IBD treated by tocilizumab
por: Helbling, R, et al.
Publicado: (2013)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

OR3-001 – RIP2 kinase is activated in Blau Syndrome and IBD
por: Foley, KP, et al.
Publicado: (2013)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
por: Mponponsuo, Kwadwo, et al.
Publicado: (2018)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Differential expression of mucosal trefoil factors and mucins in pediatric inflammatory bowel diseases
por: Jenke, Andreas C, et al.
Publicado: (2015)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Impact of Different Nutrition Strategies on Patients with Inflammatory Bowel Disease (IBD)
por: Papadimitriou, Konstantinos, et al.
Publicado: (2023)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Singh, Arshdeep, et al.
Publicado: (2023)

Microbiome analysis in a pediatric cohort of inflammatory bowel disease supports the rational of fecal microbiome therapy
por: Doganci, Aysefa, et al.
Publicado: (2014)

Thromboembolic Events in Patients with Inflammatory Bowel Disease
por: Algahtani, Farjah H., et al.
Publicado: (2016)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry
por: Torres, Esther A., et al.
Publicado: (2012)

Pulmonary thromboembolism among elderly intensive care unit patients
por: Moares, G, et al.
Publicado: (2003)

AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS)
por: Costantino, A., et al.
Publicado: (2021)

A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
por: Velez-Santiago, Alondra, et al.
Publicado: (2023)

Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2022)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

Myeloid regulatory cells: cross talk of innate and adaptive immunity to maintain the intestinal immune homeostasis in inflammatory bowel disease
por: Däbritz, Jan, et al.
Publicado: (2015)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

S10.3d Yeast Microbiome in patients with inflammatory bowel disease (IBD)
por: Vaezi, Afsane, et al.
Publicado: (2022)

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
por: Tavassoli, Samane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tj0h69ebclt04bj9jsp7oba5i